Effects of HIV-1 proteins on the fas-mediated apoptotic signaling cascade: A computational study of latent CD4+ T cell activation

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 5391 LNCS, Issue , 2009, Pages 246-259

  Jack, John ^a   Pǎun, Andrei ^a,b,c   Rodríguez Patón, Alfonso ^b  

^a Louisiana Tech University   (United States)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c NATIONAL INSTITUTE OF RESEARCH AND DEVELOPMENT FOR BIOLOGICAL SCIENCES   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CELL DEATH; CELL SIGNALING; PROTEINS; REACTION RATES;

APOPTOTIC SIGNALING CASCADES; COMPUTATIONAL STUDIES; HIV INFECTION; INDUCED APOPTOSIS; INFECTED CELLS; INITIAL CONDITIONS; SYSTEMS BIOLOGY; T CELL ACTIVATION;

T-CELLS;

EID: 60349086412     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-540-95885-7_18     Document Type: Conference Paper

References (50)

1. Algeciras-Schimnich, A., et al.: CCR5 Mediates Fas-and Caspase 8 Dependent Apoptosis of Both Uninfected and HIV Infected Primary Human CD4 T cells. AIDS 16, 1467-1478 (2002)
2. Alimonti, J., et al.: Mechanisms of CD4 T Lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Vir. 84, 1649-1661 (2003)
3. Ashkenazi, A., Dixit, V.: Death receptors: signaling and modulation. Science 281, 1305-1308 (1998)
4. Bartz, S., Emerman, M.: Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/Caspase 8. J. Vir. 73, 1956-1963 (1999)
5. Biard-Piechaczyk, M., et al.: Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Vir. 268, 329-344 (2000)
6. Briggs, J., et al.: The stoichiometry of Gag protein in HIV-1. Nature Struct. Mol. Bio. 11, 672-675 (2004)
7. Blankson, J.N., et al.: Biphasic decay of latently infected CD4+ T cells in acute HIV-1 infection. J. Infect. Dis. 182, 1636-1642 (2000)
8. Chan, D., Kim, P.: HIV entry and its inhibition. Cell 93, 681-684 (1998)
9. Chun, T.W., et al.: In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nature Med. 1, 1284-1290 (1995)
10. Chun, T.W., et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188 (1997)
11. Cicala, C., et al.: HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proc. Natl. Acad. Sci. U.S.A. 97, 1178-1183 (2000)
12. Conti, L., et al.: The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line possible implications for the pathogenesis of aids. J. Exp. Med. 187, 403-413 (1998)
13. Farnet, C., Haseltine, W.: Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Vir. 65, 1910-1915 (1991)
14. Finkel, T.: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1, 129-134 (1995)
15. Finzi, D., et al.: Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Med. 5, 512-517 (1999)
16. Gillespie, D.T.: A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J. Comp. Phy. 22, 403-434 (1976)
17. Gillespie, D.T.: Exact stochastic simulation of coupled chemical reactions. The J. Phy. Chem. 81, 2340-2361 (1997)
18. Han, T., et al.: Experimental approaches to the study of HIV-1 latency. Microbio. 5, 95-106 (2007)
19. Hashimoto, F., et al.: Modulation of Bcl-2 Protein by CD4 Cross-Linking a possible mechanism for lympphocyte apoptosis in human immunodeficiency virus infection. Blood 90, 745-753 (1997)
20. Hua, F., et al.: Effects of Bcl-2 levels on FAS signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. of Immun. 175, 6235-6237 (2005)
21. Igney, F., Krammer, P.: Death and anti-death: tumour resistance to apoptosis. Nature Rev. Can. 2, 277-288 (2002)
22. Jack, J., et al.: Discrete nondeterministic modeling of the Fas pathway. Intern. J. Found. Computer Sci. (accepted, 2008)
23. Jacotet, E., et al.: The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191, 33-45 (2000)
24. Kim, S., et al.: Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Vir. 63, 3708-3713 (1989)
25. Kinoshita, S., et al.: The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immun. 6, 235-244 (1997)
26. Lassen, K., et al.: Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathogens 2, 650-661 (2006)
27. Liu, X., et al.: DFF, a heterodimeric protein that functions downstream of Caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184 (1997)
28. McCloskey, T., et al.: Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immun. 158, 1014-1019 (1997)
29. Nabel, G., Baltimore, D.: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 344, 711-713 (1987)
30. Napolitano, G., et al.: CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of CyclinT1 promotes its nuclear localization. J. Cell. Phys. 192, 209-215 (2002)
31. Nie, Z., et al.: HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Diff. 9, 1172-1184 (2002)
32. Oyaizu, N., et al.: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 84, 2622-2631 (1994)
33. Pǎun, G.: Membrane Computing. An Introduction. Springer, Heidelberg (2002)
34. Perelson, A.S., et al.: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191 (1997)
35. Pierson, T.C., et al.: Molecular characterization of preintegration latency in HIV-1 infection. J. Virol. 76, 8518-8531 (2002)
36. Rieux-Laucat, F., et al.: Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Diff. 10, 124-133 (2003)
37. Roland-Jones, S.L., Whittle, H.C.: Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1. Nature Imm. 9, 329-331 (2007)
38. Ross, T.: Using death to one's advantage: HIV modulation and apoptosis. Leuk. 15, 332-341 (2001)
39. Scaffidi, C., et al.: Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687 (1998)
40. Selliah, N., Finkel, T.: Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death Diff. 8, 127-136 (2001)
41. Siliciano, J.D., et al.: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature Med. 9, 727-728 (2003)
42. Strack, L., et al.: Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. U.S.A. 93, 9571-9576 (1996)
43. Strain, M.C., et al.: Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. U.S.A. 100, 4819-4824 (2003)
44. World Health Organization 2007 AIDS Epidemic Update, http://www.who.int/ hiv/en/
45. Wyatt, R., Sodroski, J.: The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884-1888 (1998)
46. Yang, Y., et al.: HIV Tat binds Egr proteins and enhances Egr-dependent trans-activation of the Fas ligand promoter. J. Bio. Chem. 277, 19482-19487 (2002)
47. Zack, J.A., et al.: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990)
48. Zack, J.A., et al.: Incompletely reverse-transcribed human immunodeficiency virus type I genomes function as intermediates in the retroviral life cycle. J. Vir. 66, 1717-1725 (1992)
49. Zauli, G., et al.: Human immunodeficiency virus type 1 Nef protein sensitizes CD4+ T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. Blood 93, 1000-1010 (1999)
50. Zhou, Y., et al.: Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Vir. 79, 2199-2210 (2005)